Physician profile
Brian Patrick Doyle
NPI 1114566585
$1,045.99
in general payments reported to CMS, 2019-2025
9 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $607 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $296.61 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $160.51 | 2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $121.20 | 2024 | Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $121.13 | 2025 | Airsupra |
| Corcept Therapeutics | $120.49 | 2024 | Korlym |
| Ars Pharmaceuticals Operations, INC. | $104.20 | 2025 | Neffy |
| Insulet Corporation | $63.56 | 2025 | Omnipod |
| Inspire Medical Systems, INC. | $40.61 | 2025 | Inspire |
| Abbvie INC. | $17.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.